{
  "id": 144672,
  "title": "Amgen culls early-stage obesity candidate, makes pipeline updates",
  "url": "https://urgent.news/2026/08/04/amgen-culls-early-stage-obesity-candidate-makes-pipeline-updates",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-04T20:01:21.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/amgen-culls-early-stage-obesity-candidate-makes-pipeline-updates/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Amgen is cutting its secretive early-stage obesity candidate, AMG-513. The company hasn’t revealed much about the Phase 1 program or why it’s being discontinued. When asked for more detail, a spokesperson told Endpoints News on ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}